Cue Biopharma, Inc. (CUE) vs Inogen, Inc. (INGN)
A side-by-side comparison of Cue Biopharma, Inc. and Inogen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CUE
Cue Biopharma, Inc.
$23.75HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
INGN
Inogen, Inc.
$5.81HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
Total return — CUE vs INGN
growth of $100 · dividends reinvested · last 9yCUE -93.0% (-25.6%/yr)INGN -95.0% (-28.3%/yr)CUE compounded faster over this window
CUE INGN
CUE vs INGN: by the numbers
- •CUE is the larger company ($172M vs $157M market cap).
- •Both run net losses; INGN's is the smaller (-6.94% vs -435.83% net margin).
- •CUE grew revenue faster over the past five years (47.08% vs 1.02% CAGR).
Metrics side by side
Valuation
| Metric | CUE | INGN |
|---|---|---|
| P/S ratio | 4.58 | 0.44 |
| P/B ratio | 74.67 | 0.90 |
Profitability
| Metric | CUE | INGN |
|---|---|---|
| Gross margin | 99.69% | 48.89% |
| Operating margin | -96.56% | -8.45% |
| Net margin | -435.83% | -6.94% |
| ROE | -7104.24% | -14.07% |
| ROIC | -1039.56% | -13.94% |
Growth (annualized)
| Metric | CUE | INGN |
|---|---|---|
| Revenue CAGR (5Y) | 47.08% | 1.02% |
| Total return CAGR (5Y) | -42.42% | -32.83% |
Frequently asked
- Which has grown faster, CUE or INGN?
- Over the past five years, CUE grew revenue faster — CUE at a 47.08% CAGR versus INGN at 1.02%.
- How have CUE and INGN total returns compared?
- Over the past 5 years, CUE delivered -42.42% and INGN delivered -32.83% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cue Biopharma ROEInogen ROECue Biopharma operating marginInogen operating marginCue Biopharma revenue growthInogen revenue growthCue Biopharma free cash flowInogen free cash flow
Cue Biopharma & Inogen appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.